$MSPR
MSP Recovery, Inc.

2021 Q3 Form 10-Q Financial Statement

#000110465921139330 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $3.360M
YoY Change
Gross Profit Margin
Selling, General & Admin $4.701M
YoY Change
% of Gross Profit 139.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $171.0K
YoY Change
% of Gross Profit 5.09%
Operating Expenses $350.0K $4.872M
YoY Change
Operating Profit -$350.0K -$1.512M
YoY Change 293.71%
Interest Expense $1.074M $6.667M
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.074M -$2.726M
YoY Change -394.95%
Pretax Income $724.3K -$7.280M
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $724.3K -$7.280M
YoY Change -259.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $24.63K -$159.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $353.0K $572.1K
YoY Change
Cash & Equivalents $1.354M $1.808M $11.88M
Short-Term Investments
Other Short-Term Assets $48.94K $93.05K
YoY Change
Inventory
Prepaid Expenses $48.94K $93.05K $124.8K
Receivables
Other Receivables
Total Short-Term Assets $402.0K $665.1K $1.142M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $230.0M $230.0M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $230.0M $230.0M $230.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $402.0K $665.1K $1.142M
Total Long-Term Assets $230.0M $230.0M $230.0M
Total Assets $230.4M $230.7M $231.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.919M
YoY Change
Accrued Expenses $0.00 $2.832M $1.164M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.919M $2.832M $1.169M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.23M $19.30M
YoY Change
Total Long-Term Liabilities $18.23M $19.30M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.919M $2.832M $1.169M
Total Long-Term Liabilities $18.23M $19.30M
Total Liabilities $21.14M $22.13M $22.58M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$20.74M -$2.090M -$21.43M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$20.73M -$21.46M -$21.43M
YoY Change
Total Liabilities & Shareholders Equity $230.4M $230.7M $231.2M
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q4
OPERATING ACTIVITIES
Net Income $724.3K -$7.280M
YoY Change -259.85%
Depreciation, Depletion And Amortization $171.0K
YoY Change
Cash From Operating Activities -$219.0K -$228.6K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$296.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -5.450K
YoY Change
NET CHANGE
Cash From Operating Activities -219.0K -228.6K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 -5.450K
Net Change In Cash -219.0K -234.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$219.0K -$228.6K
Capital Expenditures -$296.0K
Free Cash Flow $67.43K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
-453098
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3189500
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Central Index Key
EntityCentralIndexKey
0001802450
dei Entity Shell Company
EntityShellCompany
true
CY2021Q3 us-gaap Cash
Cash
353032
CY2020Q4 us-gaap Cash
Cash
1017137
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
48944
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
124766
CY2021Q3 us-gaap Assets Current
AssetsCurrent
401976
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1141903
CY2021Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230008192
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230011254
CY2021Q3 us-gaap Assets
Assets
230410168
CY2020Q4 us-gaap Assets
Assets
231153157
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2918987
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1163558
CY2020Q4 lcapu Accrued Offering Cost Current
AccruedOfferingCostCurrent
5450
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2918987
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1169008
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
10176000
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
13365500
CY2021Q3 lcapu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2020Q4 lcapu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39445
dei Entity Registrant Name
EntityRegistrantName
Lionheart Acquisition Corporation II
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4117825
dei Entity Address Address Line1
EntityAddressAddressLine1
4218 NE 2nd Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33137
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
573-3900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q3 us-gaap Liabilities
Liabilities
21144987
CY2020Q4 us-gaap Liabilities
Liabilities
22584508
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-466500
lcapu Transactions Costs Associated With Initial Public Offering
TransactionsCostsAssociatedWithInitialPublicOffering
837355
us-gaap Investment Income Interest
InvestmentIncomeInterest
10306
us-gaap Investment Income Interest
InvestmentIncomeInterest
6646
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-75822
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20735459
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21431991
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-20734819
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21431351
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230410168
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231153157
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
349966
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
88889
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2503274
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
88889
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-349966
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-88889
us-gaap Operating Income Loss
OperatingIncomeLoss
-2503274
us-gaap Operating Income Loss
OperatingIncomeLoss
-88889
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3473
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6646
us-gaap Investment Income Interest
InvestmentIncomeInterest
10306
us-gaap Investment Income Interest
InvestmentIncomeInterest
6646
CY2020Q3 lcapu Transactions Costs Associated With Initial Public Offering
TransactionsCostsAssociatedWithInitialPublicOffering
837355
lcapu Transactions Costs Associated With Initial Public Offering
TransactionsCostsAssociatedWithInitialPublicOffering
837355
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070750
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-466500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3189500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-466500
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1074223
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-364209
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3199806
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-364209
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
724257
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-453098
us-gaap Net Income Loss
NetIncomeLoss
696532
us-gaap Net Income Loss
NetIncomeLoss
-453098
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21431351
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4641710
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16789641
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4669435
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-21459076
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
724257
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-20734819
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
24000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
24000
CY2020Q3 lcapu Underwriting Discount Units Issued During Period Value New Issues
UnderwritingDiscountUnitsIssuedDuringPeriodValueNewIssues
0
CY2020Q3 lcapu Private Placement Units Issued During Period Value New Issues
PrivatePlacementUnitsIssuedDuringPeriodValueNewIssues
6123874
CY2020Q3 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
25517456
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-453098
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-19822680
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
163745
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1755429
us-gaap Profit Loss
ProfitLoss
696532
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
69833
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-672023
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-182801
lcapu Payments For Investment Of Cash Into Trust Account
PaymentsForInvestmentOfCashIntoTrustAccount
230000000
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
-13368
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13368
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
lcapu Proceeds From Sale Of Units Net Of Underwriting Discounts Paid
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
225400000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6500000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
140671
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
140671
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5450
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
473487
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5450
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231451513
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-664105
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1268712
CY2020Q4 us-gaap Cash
Cash
1017137
CY2019Q4 us-gaap Cash
Cash
0
CY2021Q3 us-gaap Cash
Cash
353032
CY2020Q3 us-gaap Cash
Cash
1268712
lcapu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
5450
lcapu Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
230000000
CY2020Q3 lcapu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8050000
CY2021Q3 lcapu Dissolution Expenses Payable
DissolutionExpensesPayable
100000
CY2021Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
353032
CY2021Q3 lcapu Working Capital Deficit Net
WorkingCapitalDeficitNet
-2508819
CY2021Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q3 lcapu Minimum Net Tangible Assets Upon Redemption Of Temporary Equity
MinimumNetTangibleAssetsUponRedemptionOfTemporaryEquity
5000001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
lcapu Proceeds From Issuance Of Temporary Equity
ProceedsFromIssuanceOfTemporaryEquity
230000000
lcapu Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
-13225000
lcapu Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
12292456
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
25517456
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
230000000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q3 lcapu Related Party Transaction General And Administrative Services Expense Per Month
RelatedPartyTransactionGeneralAndAdministrativeServicesExpensePerMonth
15000
lcapu Proceeds Held In Trust Account To Repay Working Capital Loans
ProceedsHeldInTrustAccountToRepayWorkingCapitalLoans
0
lcapu Related Party Transaction Price Per Unit Upon Consummation Of Business Combination
RelatedPartyTransactionPricePerUnitUponConsummationOfBusinessCombination
10.00
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 lcapu Percentage Of Common Stock Outstanding For Conversion Basis
PercentageOfCommonStockOutstandingForConversionBasis
0.20

Files In Submission

Name View Source Status
0001104659-21-139330-index-headers.html Edgar Link pending
0001104659-21-139330-index.html Edgar Link pending
0001104659-21-139330.txt Edgar Link pending
0001104659-21-139330-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lcapu-20210930.xsd Edgar Link pending
lcapu-20210930x10q.htm Edgar Link pending
lcapu-20210930x10q_htm.xml Edgar Link completed
lcapu-20210930xex31d1.htm Edgar Link pending
lcapu-20210930xex31d2.htm Edgar Link pending
lcapu-20210930xex32d1.htm Edgar Link pending
lcapu-20210930xex32d2.htm Edgar Link pending
lcapu-20210930_cal.xml Edgar Link unprocessable
lcapu-20210930_def.xml Edgar Link unprocessable
lcapu-20210930_lab.xml Edgar Link unprocessable
lcapu-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending